Heo J, Kim YN, Shin S, Lee K, et al. Serial circulating-tumor DNA analysis with a tumor naive next-generation sequencing panel detects minimal residual disease and predicts outcome in ovarian cancer. Cancer Res 2023 Dec 1. doi: 10.1158/0008-5472.CAN-23-1429.
PMID: 38038965